Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Botulinum Neuromodulators for Facial Synkinesis
NCT03048383Phase 4Completed
- Sponsor
- University of Utah
- Start
- Jul 2012
- Primary completion
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of botulinum toxin type A in Facial synkinesis, sponsored by University of Utah. Started Jul 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Facial synkinesis
Beyond the preview
Go deeper on NCT03048383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03048383.